Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence
Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted …

Cancer has become a major disease burden across the globe. It was estimated that 4.29
million new incident cases and 2.81 million death cases of cancer would occur in 2015 in …

Importance Despite evidence of an association between reproductive factors and
endometrial cancer risk, prospective studies have been conducted mainly in non-Asian …

Endometrial cancer risk has been associated with reproductive factors (age at menarche,
age at menopause, parity, age at first and last birth, time since last birth and use of oral …

Endometrial cancer is the most common malignancy of women in developed countries, and
its incidence is 10 times higher than in developing countries. Endometrial cancer is most …

Evidence between age at menarche and endometrial cancer risk have been controversial.
Therefore, we conducted a meta-analysis of prospective studies to analyze the …

Background Oral contraceptives are known to influence the risk of cancers of the female
reproductive system. Evidence regarding the relationship between injectable contraceptives …

Ages at menarche and menopause have been shown to be associated with adverse health
outcomes in later life. For example, earlier menarche and later menopause have been …

Endometrial cancer is a disease primarily driven by cumulative exposure to estrogen
unopposed by progesterone. Reproductive factors associated with changes in endogenous …

Objective To provide guidelines for health care providers on the use of contraceptive
methods to prevent pregnancy and on the promotion of healthy sexuality. Outcomes Overall …